Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

NCT06208917 ↗

Phase 3 Recruiting 376 enrolled Yizhuo Zhang

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose is to evaluate the efficacy of ondansetron oral soluble film plus dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) with MEC/HEC chemotherapy in children with solid tumor.

Timeline

Start: 2023-07-09
Primary completion: 2026-07-01
Completion: 2027-01-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ondansetron	Other / unclassified	—	Oral
Background	Dexamethasone	Small molecule	—	Oral

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Summary

Timeline

Drugs

Indications